Kriti Arora

Kriti Arora

UNVERIFIED PROFILE

Are you Kriti Arora?   Register this Author

Register author
Kriti Arora

Kriti Arora

Publications by authors named "Kriti Arora"

Are you Kriti Arora?   Register this Author

25Publications

722Reads

21Profile Views

NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.

J Cell Biochem 2020 Apr 11;121(4):3010-3023. Epub 2019 Nov 11.

Department of Biochemistry, Institute of Home Economics, University of Delhi, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.29560DOI Listing
April 2020

Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy]benzyl)arylamine derivatives as potential antitubercular agents.

Drug Dev Res 2019 Nov 28. Epub 2019 Nov 28.

Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ddr.21623DOI Listing
November 2019

C4-Phenylthio β-lactams: Effect of the chirality of the β-lactam ring on antimicrobial activity.

Bioorg Med Chem 2019 Oct 20;27(20):115050. Epub 2019 Aug 20.

Department of Chemistry, American University, Washington, DC 20016, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2019.115050DOI Listing
October 2019

Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.

Mol Divers 2019 Sep 10. Epub 2019 Sep 10.

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11030-019-09990-zDOI Listing
September 2019

Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-Oxidase.

J Med Chem 2018 11 5;61(22):9952-9965. Epub 2018 Nov 5.

Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Bethesda , Maryland 20892 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.8b00883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257622PMC
November 2018

Childhood Sarcoidosis Presenting as Recurrent Facial Palsy.

Indian Pediatr 2018 Apr;55(4):339-340

Department of Dermatology, CHL Hospital; Indore, Madhya Pradesh, India.

View Article

Download full-text PDF

Source
April 2018

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis.

Eur Respir J 2017 12 28;50(6). Epub 2017 Dec 28.

Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02023-2017DOI Listing
December 2017

Susceptibility of Mycobacterium tuberculosis Cytochrome Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome .

Antimicrob Agents Chemother 2017 10 22;61(10). Epub 2017 Sep 22.

MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Department of Pathology, University of Cape Town, Cape Town, South Africa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01338-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610507PMC
October 2017

Correction for Arora et al., "Respiratory Flexibility in Response to Inhibition of Cytochrome Oxidase in ".

Antimicrob Agents Chemother 2017 09 24;61(9). Epub 2017 Aug 24.

Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01429-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571366PMC
September 2017

Effectiveness of student-led objective tutorials in pharmacology teaching to medical students.

Indian J Pharmacol 2016 Oct;48(Suppl 1):S78-S82

Department of Pharmacology, KLE University's J N Medical College, Belagavi, Karnataka, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0253-7613.193321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178063PMC
October 2016

Synthesis and evaluation of functionalized benzoboroxoles as potential -tuberculosis agents.

Tetrahedron 2016 Jun 17;72(26):3795-3801. Epub 2016 Mar 17.

Integrated Biosciences Graduate Program, University of Minnesota, MN 55812, USA; Department of Chemistry and Biochemistry, University of Minnesota Duluth, Duluth, MN 55812, USA; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN 55812, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tet.2016.03.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021310PMC
June 2016

Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.

Antimicrob Agents Chemother 2014 Nov 25;58(11):6962-5. Epub 2014 Aug 25.

Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.03486-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249445PMC
November 2014

Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.

Mol Microbiol 2012 Oct 28;86(2):367-81. Epub 2012 Aug 28.

Tuberculosis Research Section, National Institute of Allergy and Infectious Disease, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2958.2012.08199.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2958.2012.08199.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468717PMC
October 2012

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.

Antimicrob Agents Chemother 2012 Jun 26;56(6):3384-7. Epub 2012 Mar 26.

Tuberculosis Research Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.05690-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370771PMC
June 2012

SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.

Antimicrob Agents Chemother 2012 Apr 17;56(4):1797-809. Epub 2012 Jan 17.

Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.05708-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318387PMC
April 2012

Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatis.

J Bacteriol 2008 Jun 11;190(12):4291-300. Epub 2008 Apr 11.

Washington State University, School of Molecular Biosciences, Pullman, WA 99164, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JB.00023-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2446759PMC
June 2008